Bio-Techne
Business Services · Minnesota, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
614 Mckinley Pl NE, Minneapolis, Minneso...Phone Number
(612) 379-2956Website
www.bio-techne.comRevenue
$1.2 BillionStock Symbol
TECHIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
2
2
1
1
1
About Bio-Techne
Founded in 1981, Bio-Techne Corporation is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses.Explore more
Bio-Techne Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Bio-Techne your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Bio-Techne launches new products
Click to see if Bio-Techne had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Bio-Techne recently announced quarterly report
Check if Bio-Techne has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Bio-Techne has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Bio-Techne is spiking on competitors!
Bio-Techne, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Bio-Techne
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Explore company insights
Get a deeper look into Bio-Techne's structure, leadership, and market position:
Company Profile Activity
Activity Insights
Bio-Techne is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Bio-Techne is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Bio-Techne.
Bio-Techne Tech Stack
A closer look at the technologies used by Bio-Techne
Most Recent Scoops
Person-Based
Stake & Stock Ownership, Finance, Tax
Open Position
Person-Based
Financial Reporting
Open Position
Person-Based
Stake & Stock Ownership, Finance
Bio-Techne News & Media
Bio-Techne Opens New Customer Experience Center in Düsseldorf to Accelerate Scientific Discovery and Customer Collaboration
New flagship facility provides hands-on access to Bio-Techne technologies, workflows and scientific expertise Regional hub will support researchers and organizations across the DACH and broader EMEA regions Center strengthens collaboration, training and innovation within Europe's life sciences community MINNEAPOLIS and DÜSSELDORF, Germany, Sept. 22, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic products, today announcBRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Centerspace (NYSE – CSR), Fulcrum Therapeutics, Inc. (Nasdaq – FULC), Weave Communications, Inc. (NYSE – WEAV), Bio-Techne Corporation (Nasdaq – TECH)
BALA CYNWYD, Pa., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.Bio-Techne Achieves Science Based Targets Validation and Reports Significant Progress Toward Climate Goals
Fiscal 2026 highlights: Science Based Targets initiative validates Bio-Techne's Scope 1, 2 and 3 greenhouse gas reduction targets Market-based Scope 1 and 2 emissions reduced 49% year-over-year More than half of the company's electricity consumption now comes from renewable sources First...BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fulcrum Therapeutics, Inc. (Nasdaq – FULC), Weave Communications, Inc. (NYSE – WEAV), Iridium Communications Inc. (Nasdaq – IRDM), Bio-Techne Corporation (Nasdaq – TECH)
BALA CYNWYD, Pa., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Bio-Techne
Sign Up For FreeTo access detailed company insights
Founded in 1981, Bio-Techne Corporation is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and prov... Read More
